bpc-157 anti-inflammatory effects tnf-α il-6 Modulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles BPC-157 Peptide Therapy | Regenerative

It was originally developed with the intention of fighting obesity by stimulating lipolysis (the breakdown of fats) and inhibiting lipogenesis, the transformation of non-fat food materials into body fat

### Alternative: 2.5mg/mL (Better for Low Doses) | Vial Size | BAC Water to Add | Concentration | Volume per 0.5mg Dose | |-----------|-----------------|---------------|-----------------------| | 5mg | 2.0mL | 2.5mg/mL | 0.20mL | | 10mg | 4.0mL | 2.5mg/mL | 0.20mL | This lower concentration produces larger injection volumes easier to measure precisely, but more volume per shot

Meet with our provider in-office or through secure telehealth

No account